• EGCG Nanoparticles Enhance FLASH Radiotherapy

  2026-09-01

  Xu et al. developed functionalized, self-assembled EGCG nanoparticles (BENPs) to increase ROS generation, DNA damage, and tumor-cell killing during FLASH radiotherapy. In a 4T1 breast tumor model, the combination also stimulated antitumor immune features, although further work is needed to establish pharmacokinetics, optimal dosing, and clinical transferability.

• SIRT1/2 Inhibitor IV: Applied Research Workflows

  2026-08-31

  Build mechanism-focused assays around SIRT1/2 Inhibitor IV (cambinol) to connect deacetylase activity with lactate signaling, Ran modification, p53 acetylation, and tumor-cell responses. This practical guide separates evidence-backed observations from starting conditions for CNS injury, cancer, and metabolic pathway experiments.

• Masitinib (AB1010): KIT/PDGFR Workflow Guide

  2026-08-31

  Masitinib (AB1010), SKU A2942, is a DMSO-compatible phenylaminothiazole-type kinase inhibitor for workflows involving KIT, PDGFRα, PDGFRβ, mast cells, and selected cancer models. It is not suitable for aqueous or ethanol-based protocols, broad-spectrum kinase screens, or clinical treatment decisions without independent evidence and validation.

• HNF4A-AS1 and Sorafenib Resistance in HCC

  2026-08-30

  A 2024 Theranostics study identifies the liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its mechanistic model links HNF4A-AS1 to METTL3-dependent m6A modification of DECR1 mRNA, polyunsaturated fatty acid retention, and drug sensitivity.

• CD36 Lipid Signaling Drives Immune Escape in AML

  2026-08-29

  Guo et al. identify a non-canonical CD36 lipid-sensing program in AML that links oxidized LDL and palmitate uptake to innate immune signaling, T-cell suppression, and resistance to decitabine. The study provides a mechanistic rationale for combining hypomethylating therapy with lipid-restriction strategies, while also defining important limits for translating the findings into other immunometabolic models.

• CD36 Lipid Signaling Drives Immune Escape in AML

  2026-08-28

  Guo et al. identify a non-canonical CD36-dependent lipid-signaling program in acute myeloid leukemia that links oxidized LDL and palmitate uptake to T cell suppression and resistance to decitabine. The study suggests that statin-mediated disruption of leukemic CD36 signaling may improve hypomethylating-agent efficacy, while also defining important metabolic and immunologic variables for future AML studies.

• Metoprolol Research Workflows for Beta1 Assays

  2026-08-28

  Build reproducible beta1-receptor, cardiovascular, inflammation, and exploratory tumor-biology assays with a defined small-molecule perturbation. This guide combines fresh-solution handling, concentration-response design, disease-state pharmacokinetic thinking, and troubleshooting strategies for Metoprolol BA2737.

• Temozolomide Workflows for Glioma DNA Damage

  2026-08-27

  Temozolomide provides a controlled way to impose DNA methylation stress in glioma and other cancer models. This guide connects practical dosing, ATRX-stratified combination assays, and troubleshooting strategies for DNA repair mechanism research and chemotherapy resistance studies.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-27

  A 2024 Neuron study identifies a brain-to-spinal pathway linking MOR-expressing neurons in the lateral parabrachial nucleus to dynorphin and KOR-GABA circuits that regulate morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The findings distinguish mechanical opioid side effects from better-established thermal mechanisms and provide a circuit framework for receptor-specific pain mechanism research.

• Pterostilbene Preserves Dermal Fibroblast Mitochondria

  2026-08-26

  Zhou et al. show that pterostilbene reduces senescence in human dermal fibroblasts by improving mitochondrial quality and promoting mitophagy. The study combines cellular senescence, mitochondrial function, imaging, and UVB-exposed mouse models, providing a useful framework for evaluating dermal aging interventions.

• EZ Cap™ Firefly Luciferase mRNA as an LNP Probe

  2026-08-26

  EZ Cap™ Firefly Luciferase mRNA can do more than report gene expression: it can help separate payload quality from delivery-system performance. This article connects Cap 1 biology with lipid nanoparticle design and practical assay decisions.

• MEDUSA Links Death Rates to Drug Mechanisms

  2026-08-25

  Honeywell and colleagues introduce MEDUSA, a simulation-assisted framework that separates drug-treated cell growth from cell death in functional genomic screens. Applied to DNA damage, the method reveals that p53 loss redirects cells from apoptosis toward a respiration-dependent nonapoptotic death program, offering a more precise way to identify genetic determinants of drug lethality.

• Chemistry of Silybin: Structure, Separation, and Derivatives

  2026-08-25

  Křen and colleagues’ review reconstructs more than five decades of silybin chemistry, with particular emphasis on absolute stereochemical assignment, separation of silybin A and B, and derivative synthesis. Its practical importance is that it distinguishes the defined flavonolignan from the chemically heterogeneous silymarin mixture, improving the interpretation of analytical and biological experiments.

• Cy5 RNA labeling kit: Probe Workflow Guide

  2026-08-24

  Build fluorescent RNA probes by T7 transcription while tuning Cy5-UTP substitution to balance signal and transcript yield. This practical guide connects probe preparation with spatial hybridization, Northern analysis, and fluorescence tracking in RNA-delivery studies.

• Mdivi-1 Workflows for DRP1 and Mitochondrial Fission

  2026-08-24

  Mdivi-1 enables acute, cell-permeable suppression of DRP1-dependent mitochondrial fission for apoptosis assays, mitochondrial dynamics research, and ischemic-retina models. This practical guide connects dosing and imaging workflows with the emerging extracellular-matrix-to-mitochondria signaling framework.

7318 records 1/488 page Next 12345 下5页 Last page